# Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Exclusive CADx Patent Positions IzoView as First-Mover in AI-Enhanced Breast CT

* Exclusive U.S. patent rights for computer-aided diagnosis (“CADx”) with breast CT secured through a global license with the University of California
* CADx planned as a post-market software upgrade, creating dual revenue streams via upgrade incentives and licensing
* Patent exclusivity paired with proprietary machine-learning reconstruction establishes a durable moat in dedicated breast imaging

 The AI Integration Challenge in Medical Imaging

 Artificial intelligence has long promised to revolutionize radiology, but most applications remain stuck between theoretical potential and real-world limitations. CADx systems can enhance detection, yet they face hurdles: lack of specialized datasets, workflow disruptions, and intellectual property barriers.

 In breast imaging, the stakes are higher. Nearly half of screening patients present with dense breast tissue, where overlapping structures can mask cancers. General-purpose AI retrofits struggle to overcome these limitations. True innovation requires purpose-built platforms that integrate AI from the…

 Read More>>

 NOTE TO INVESTORS: The latest news and updates relating to IZOZF are available in the company’s newsroom at ibn.fm/IZOZF

 About TechMediaWire

 TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit https://www.TechMediaWire.com

 Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

 TechMediaWireLos Angeles, CAwww.TechMediaWire.com310.299.1717 OfficeEditor@TechMediaWire.com

 TechMediaWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/tmw/izotropic-corporation-cse-izo-otcqb-izozf-exclusive-cadx-patent-positions-izoview-as-first-mover-in-ai-enhanced-breast-ct/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/izotropic-secures-exclusive-ai-breast-ct-patent-revolutionizing-cancer-detection/625a316c744330e8b837a2d6006e69ad) 

 



[Reddit Post](https://www.reddit.com/r/technology_press/comments/1neig8r/izotropic_secures_exclusive_ai_breast_ct_patent/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/259/11/ulnaeyub.webp)